Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1‐ and SIRT3‐mediated autophagy induction

Tris (dibenzylideneacetone) dipalladium (Tris DBA), a small‐molecule palladium complex, can inhibit cell growth and proliferation in pancreatic cancer, lymphocytic leukaemia and multiple myeloma. Given that this compound is particularly active against B‐cell malignancies, we have been suggested that...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chung‐Yao, Hua, Kuo‐Feng, Yang, Shin‐Ruen, Tsai, Yi‐Shan, Yang, Shun‐Min, Hsieh, Chih‐Yu, Wu, Chia‐Chao, Chang, Jia‐Feng, Arbiser, Jack L., Chang, Chiz‐Tzung, Chen, Ann, Ka, Shuk‐Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753881/
https://www.ncbi.nlm.nih.gov/pubmed/33135320
http://dx.doi.org/10.1111/jcmm.15663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753881/
https://www.ncbi.nlm.nih.gov/pubmed/33135320
http://dx.doi.org/10.1111/jcmm.15663

Ejemplares similares